|
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
Amira Marouf
,
Sammara Chaubard
,
Raphaël Liévin
,
Jean-Marie Michot
,
Nicolas Molinari
et al.
Article dans une revue
hal-04926143
v1
|
|
Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome
Marion Plaçais
,
Ariane Laparra
,
Alexandre Thibault Jacques Maria
,
Nora Kramkimel
,
Audrey Perret
et al.
Article dans une revue
hal-04960905
v1
|
|
Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez
,
Capucine Baldini
,
Arnaud Bayle
,
Arnaud Pages
,
François Xavier Danlos
et al.
Article dans une revue
inserm-04981546
v1
|
|
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
Yuta Ito
,
Amira Marouf
,
Yasunori Kogure
,
Junji Koya
,
Raphaël Liévin
et al.
Article dans une revue
inserm-04773439
v1
|
|
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series
Cyrille Coustal
,
Juliette Vanoverschelde
,
Xavier Quantin
,
Candice Lesage
,
Jean-Marie Michot
et al.
Article dans une revue
hal-04116183
v1
|
|
S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
Amira Marouf
,
Sammara Chaubard
,
J.M. Michot
,
Julien Rossignol
,
Camille Golfier
et al.
Article dans une revue
hal-04406218
v1
|
|
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
Vincent Camus
,
Aurélien Belot
,
Lucie Oberic
,
David Sibon
,
Hervé Ghesquières
et al.
Article dans une revue
hal-04946564
v1
|
|
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
C. Corti
,
G. Antonarelli
,
F. Scotté
,
J.P. Spano
,
J. Barrière
et al.
Article dans une revue
hal-03955867
v1
|
|
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study
Charlotte Cabanié
,
Samy Ammari
,
Sophie Hans
,
Cedric Pobel
,
Ariane Laparra
et al.
Article dans une revue
hal-04532592
v1
|
|
Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit
Adrien Joseph
,
Audrey Simonaggio
,
Annabelle Stoclin
,
Antoine Vieillard-Baron
,
Guillaume Geri
et al.
Article dans une revue
hal-02996544
v1
|
|
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
Guillaume Manson
,
Alexandre Thibault Jacques Maria
,
Florence Poizeau
,
François-Xavier Danlos
,
Marie Kostine
et al.
Article dans une revue
hal-02530293
v1
|
|
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
Ahmed Mekki
,
Laurent Dercle
,
Philip Lichtenstein
,
Aurélien Marabelle
,
Jean-Marie Michot
et al.
Article dans une revue
hal-04534637
v1
|
|
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience
Sylvain Besle
,
Emilien Schultz
,
Antoine Hollebecque
,
Andreea Varga
,
Capucine Baldini
et al.
Article dans une revue
hal-04508716
v1
|
|
Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease
Jean-Marie Michot
,
Françoise Driss
,
Corinne Guitton
,
Julia Moh Klaren
,
François Lefebvre
et al.
Article dans une revue
istex
inserm-01995062
v1
|